Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Salazopyrin EN-Tabs 500mg
0105010E0BBABAB
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | 33,832 |
|
Salazopyrin 500mg tablets
0105010E0BBAAAA
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | 15,870 |
|
Salazopyrin 500mg suppositories
0105010E0BBACAC
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | 29 |
|
Salazopyrin 250mg/5ml oral suspension
0105010E0BBAEAE
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | No data available |
|
Salazopyrin 3g/100ml enema
0105010E0BBADAD
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.